Portfolio company
Interpace Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Interpace Biosciences provides molecular diagnostic tests and pathology services for cancer risk evaluation to healthcare providers and pharmaceutical companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pathology
This company provides anatomic and molecular diagnostic testing services to healthcare providers, specializing in women's health and oncology.
Epigenomics
This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.
Veracyte
This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.
Neumann Diagnostics
This company develops molecular and epigenetic diagnostic tests for cervical cancer screening and human papillomavirus detection for healthcare laboratories and clinical providers.
PathGroup
This company provides anatomic, clinical and molecular pathology services and laboratory diagnostic testing to hospitals, medical practices and surgery centres.
Foresight Diagnostics
This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.
NX Pharmagen
This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.
Delfi Diagnostics
This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.
